NeuroSense Therapeutics (NRSN) Shares Outstanding (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Shares Outstanding (Entity) came in at $25.5 million in Q4 2025, up 36.98% year-over-year from $18.6 million in Q4 2024, and up 36.98% quarter-over-quarter from $18.6 million in Q4 2024.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Shares Outstanding (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Shares Outstanding (Entity) across 6 years of filings, most recently posting $25.5 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 36.98% year-over-year to $25.5 million; the TTM figure through Dec 2025 stood at $25.5 million (up 36.98% YoY), while the FY2025 annual figure was $25.5 million, up 36.98% from the prior year.
- Shares Outstanding (Entity) came in at $25.5 million for Q4 2025 at NeuroSense Therapeutics, up from $18.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $25.5 million in Q4 2025 to a low of $6.2 million in Q4 2021.
- Average Shares Outstanding (Entity) over 5 years is $15.5 million, with a median of $15.4 million recorded in 2023.
- Year-over-year, Shares Outstanding (Entity) climbed 11.83% in 2021 and jumped 88.71% in 2022.
- Over 5 years, Shares Outstanding (Entity) stood at $6.2 million in 2021, then jumped by 88.71% to $11.8 million in 2022, then surged by 30.53% to $15.4 million in 2023, then increased by 20.96% to $18.6 million in 2024, then soared by 36.98% to $25.5 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $25.5 million in Q4 2025, $18.6 million in Q4 2024, and $15.4 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 398.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 61.30 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 720.78 Mn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 25.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 25.48 Mn |
| Jun 30, 2025 | 18.60 Mn |
| Dec 31, 2024 | 18.60 Mn |
| Sep 30, 2024 | 13.64 Mn |
| Jun 30, 2024 | 13.64 Mn |
| Mar 31, 2024 | 13.64 Mn |
| Dec 31, 2023 | 13.64 Mn |
| Sep 30, 2023 | 11.50 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 11.50 Mn |
| Dec 31, 2022 | 11.50 Mn |
| Sep 30, 2022 | 6.24 Mn |
| Jun 30, 2022 | 6.24 Mn |
| Mar 31, 2022 | 6.24 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Dec 31, 2020 | 5.52 Mn |
API Access
NeuroSense Therapeutics Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();